Trial Condition(s):

Pulmonary arterial hypertension

Efficacy of Ventavis used in real-life setting. (SPHERA)

Bayer Identifier:

15308

ClinicalTrials.gov Identifier:

NCT01355380

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This is a registry of patients diagnosed with pulmonary arterial hypertension, scheduled for treatment with Ventavis.
Typical clinical measures and quality of life will be prospectively followed in 12 months period.

Inclusion Criteria
- Pulmonary arterial hypertension in WHO functional class III or IV
  - Age 18+
  - Patients newly treated with Ventavis or switched from sildenafil
Exclusion Criteria
- Retrospective documentation is not allowed

Trial Summary

Enrollment Goal
55
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Ventavis (Iloprost, BAYQ6256)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Poland

Status
Completed
 

Trial Design